Eli Lilly says a new starting dose regimen for its Alzheimer's disease therapy Kisunla reduces the risk of side effects that have stood in the way of approvals and reimbursement decisions for ...

The Oppo Pad Air is the brand's first tablet entry in the Indian market. Oppo takes a budget approach with this one and focuses on quality instead of performance, making it into a tablet that is built ...

It was backordered but then I got an email saying it was in stock and I was SO excited. Not only is it affordable, but it's ...

While we’re excited for the holidays and to give some of the best gifts to our loved ones this year, we’re even more excited ...

Earnings Report 1.900 USD Q4 2021 Earnings Release 02/03/2022 Indices Commodities Currencies Stocks ...

Patients who received both the Lilly drug and PAP therapy lost an average of 50 pounds, or 20% of their body weight, the company said. While the most common side effects for patients on Zepbound ...

In a study, people who took Zepbound had fewer breathing interruptions. The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

Daniel Ghinn explores the processes behind launching LillyPad, global pharmaceutical company Eli Lilly’s corporate blog, which has associated social media channels on YouTube, Facebook and Twitter.

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...